Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asthma in children.

G L Larsen1

  • 1Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.

The New England Journal of Medicine
|June 4, 1992
PubMed
Summary
This summary is machine-generated.

Childhood asthma remains a significant health concern, with potential for increased mortality due to improper medication use. Optimal asthma therapy requires an open mind, considering both anti-inflammatory and beta-agonist treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Absorption, distribution, metabolism and excretion (ADME) study with 2,2',4,4',5,6'-hexabromodiphenyl ether (BDE-154) in male Sprague-Dawley rats.

Xenobiotica; the fate of foreign compounds in biological systems·2009
Same author

Mechanisms of cholinergic dysfunction in rabbits following recurrent aspiration of cow's milk.

Pediatric pulmonology·2001
Same author

Metabolism of [14C]1,2,7,8-tetrachlorodibenzo-p-dioxin in a ruminating Holstein calf.

Xenobiotica; the fate of foreign compounds in biological systems·2001
Same author

Metabolism of N-isopropylacetanilide in rat.

Xenobiotica; the fate of foreign compounds in biological systems·2001
Same author

Differences between adult and childhood asthma.

Disease-a-month : DM·2001
Same author

Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus.

American journal of respiratory and critical care medicine·2001
Same journal

Ebola at 50 - Lessons for Outbreak Response and Preparedness.

The New England journal of medicine·2026
Same journal

Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.

The New England journal of medicine·2026
Same journal

Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

The New England journal of medicine·2026
Same journal

Hypertension Control in Low-Income Patients. Reply.

The New England journal of medicine·2026
Same journal

Hypertension Control in Low-Income Patients.

The New England journal of medicine·2026
Same journal

Hypertension Control in Low-Income Patients.

The New England journal of medicine·2026
See all related articles

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Respiratory Medicine

Background:

  • Childhood asthma continues to cause significant morbidity and mortality despite medical advances.
  • Over-reliance on beta-agonists and underutilization of anti-inflammatory drugs are linked to increased asthma mortality in children.
  • Airway inflammation, even in mild asthma, and its impact on airway responsiveness are increasingly recognized.

Purpose of the Study:

  • To highlight the challenges in managing childhood asthma.
  • To emphasize the need for a comprehensive approach to asthma therapy.
  • To advocate for an open-minded strategy in treating severe pediatric asthma.

Main Methods:

  • Review of current understanding of asthma pathophysiology and treatment.

Related Experiment Videos

  • Analysis of the impact of medication overuse and underuse on asthma outcomes.
  • Consideration of clinical observations in severe pediatric asthma cases.

    • Main Results:

    • Current anti-inflammatory medications are not universally effective for all pediatric asthma patients.
    • Appropriate corticosteroid use does not always resolve chronic severe asthma in children.
    • The complexity of asthma suggests current therapeutic concepts may be too simplistic.

    Conclusions:

    • Healthcare providers must remain flexible in their approach to optimal asthma management.
    • A personalized and adaptive therapeutic strategy is crucial for severe childhood asthma.
    • Further research into novel and effective anti-inflammatory agents is warranted.